Eagle Pharmaceuticals Inc (EGRX) — Cash Flow Quality Index
Eagle Pharmaceuticals Inc (EGRX) has a Cash Flow Quality Index of -0.02x as of June 2023. Operating cash flow of $-126.00K is below net income of $5.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Eagle Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eagle Pharmaceuticals Inc Cash Flow Quality Index (2015–2020)
Historical Cash Flow Quality Index for Eagle Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Eagle Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Eagle Pharmaceuticals Inc (2015–2020)
Year-by-year earnings quality comparison for Eagle Pharmaceuticals Inc. For live market cap and the full company financial profile, see market cap of Eagle Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 4.13x | $49.50 Million | $11.99 Million | ▲ +5.5% |
| 2019 | 3.91x | $55.99 Million | $14.31 Million | ▲ +138.2% |
| 2018 | 1.64x | $52.38 Million | $31.90 Million | ▲ +44.8% |
| 2017 | 1.13x | $58.92 Million | $51.94 Million | ▲ +73.6% |
| 2016 | 0.65x | $53.21 Million | $81.45 Million | ▲ +117.3% |
| 2015 | -3.78x | $-9.72 Million | $2.57 Million | — |